Filing Flows › Materials › Hong Yuan Holding (HGYN)
Hong Yuan Holding (HGYN) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Sep 18, 2026 · Hong Yuan Holding (HGYN) Q2 2026 earnings results →
Q2 2026 Revenue down 72% year over year to $32K · 298¢ of every $1 of revenue lost · operating margin -296.9%
Hong Yuan Holding made $32K in Q2 2026 (-72% Y/Y). Operating margin -296.9%, net loss $96K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Sep 18, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $32K in Q2 2026, down 71% year over year and down 26% from the previous quarter.
Gross margin was 66.7%, down 18.0 points from Q2 2025. Operating costs exceeded revenue by $95K, an operating margin of -296.9%. Operating expenses grew 103% against a revenue fall of 71%. The fastest-growing cost line was Sales & marketing (+633%). The quarter ended with a net loss of $96K, wider than the previous quarter's $94K loss. Minority interests bore $1K of it: to shareholders the quarter was a loss of $94K.
Operating cash flow was −$8K. Non-cash charges added back $0K of depreciation. Working capital and other items added $88K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Sep 18, 2026 | $32K | -72% | -296.9% | −$96K | −$8K |
| Q1 2026 | 10-Q | Jun 22, 2026 | $44K | -82% | -216.4% | −$94K | −$3K |
| Q4 2025 | 10-K | May 8, 2026 | $226K | -2% | 18.9% | $39K | $382 |
| Q3 2025 | 10-Q | Nov 19, 2025 | $258K | 3,039× | 21.6% | $49K | −$27K |
| Q2 2025 | 10-Q | Aug 19, 2025 | $113K | +642% | 33.6% | $30K | $11K |
| Q1 2025 | 10-Q | Jul 31, 2025 | $241K | — | 16.7% | $38K | −$13K |
| Q4 2024 | 10-K | Jul 3, 2025 | $230K | — | -28.3% | $23K | $6K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Hong Yuan Holding
Hong Yuan Holding Group (“We”, “the Company”, “Hong Yuan”) was incorporated on September 29, 2001 in the State of Nevada under the name of Biocorp North America Inc. On March 18, 2005, the Company filed an amendment to its certificate of incorporation to change its name to Cereplast, Inc. On February 10, 2014, the Company, filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Indiana (the “Bankruptcy Court “). On February 14, 2014, the Company filed a motion in the Bankruptcy Court seeking to convert the Company’s Chapter 11 Case to a Chapter 7 bankruptcy case. On March 27, 2014, the court granted the Company’s motion and on that date the Company’s Chapter 11 Case was converted to a Chapter 7 case.
In its own words, from its 10-Q, filed Jun 22, 2026.
Hong Yuan Holding against its Plastic Materials, Synth Resins & Nonvulcan Elastomers peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -72% against the peers' median +9%. Operating margin: -296.9% against the peers' median 9.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| HGYN Hong Yuan Holding | Q2 2026 | $32K | -72% | -296.9% |
| DOW Chemical | Q2 2026 | $12.1B | +20% | 7.2% |
| DOW DOW | Q3 2026 | $11.3B | +13% | 5.7% |
| EMN Eastman Chemical | Q3 2026 | $2.4B | +8% | 10.4% |
| DD DuPont de Nemours | Q3 2026 | $1.9B | +4% | 12.5% |
| ALB Albemarle | Q3 2026 | $1.6B | +19% | 9.5% |
| AVNT Avient | Q3 2026 | $891M | +10% | 9.3% |
| TSEOQ Trinseo | Q2 2026 | $845M | +8% | 0.0% |
| HXL Hexcel | Q3 2026 | $496M | +9% | 11.0% |
Source: Hong Yuan Holding 10-Q on SEC EDGAR · CIK 1324759 · Plastic Materials, Synth Resins & Nonvulcan Elastomers
More on HGYN
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results